Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Completed · Phase 2

Conditions studied: Eyelash Hypotrichosis

In brief

This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

Key facts

Study ID

NCT01064882

Run by

Allergan

People needed

104

Starts

2010-03-01

Expected to finish

2010-07-01

Last updated by the study team

2011-12-09

Who can join

Age: 30 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female Caucasians between 30 and 55 years of age, with hypotrichosis (inadequate or not enough) of the eyelashes
• Eyelash prominence assessment of minimal or moderate

You may not qualify if…

• Any eye disease or abnormality
• Any permanent eyeliner or eyelash implants of any kind
• Any ocular surgery, semi-permanent eyelash tint, or eyelash extension application during the 3 months prior to study entry
• Any use of prescription eyelash growth products
• Any use of over the counter eyelash growth products during the 6 months prior to baseline
• Any use of treatments that may affect hair growth during the 6 months prior to baseline

Where it is running

• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.